| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOZTJmNDVxeVNLMERaZWkxbUZxSTBOLVpOdUM5MHV5MEVoYVZUczd6Ty11T3pKSXBmWFpKVGp6Ukw1NzBpYkltUlF3SG5XSnREVHRjdGNxU0NGbTJITGtYT2U1UTVkOS1zWEZmOGRjS0pTVmpXR183ZFpHTnVTc0s2aUR5bmRrWlVuMEp5V3RDZmpySDFWQnV3aVBEN3dZeW4zdUVkQW5nQnl2Zlpp?oc=5","as_of":"2026-04-18T12:49:20.988134+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOZTJmNDVxeVNLMERaZWkxbUZxSTBOLVpOdUM5MHV5MEVoYVZUczd6Ty11T3pKSXBmWFpKVGp6Ukw1NzBpYkltUlF3SG5XSnREVHRjdGNxU0NGbTJITGtYT2U1UTVkOS1zWEZmOGRjS0pTVmpXR183ZFpHTnVTc0s2aUR5bmRrWlVuMEp5V3RDZmpySDFWQnV3aVBEN3dZeW4zdUVkQW5nQnl2Zlpp?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_a7c7269a05ebb0eb","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-18T12:49:35.907116+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOZTJmNDVxeVNLMERaZWkxbUZxSTBOLVpOdUM5MHV5MEVoYVZUczd6Ty11T3pKSXBmWFpKVGp6Ukw1NzBpYkltUlF3SG5XSnREVHRjdGNxU0NGbTJITGtYT2U1UTVkOS1zWEZmOGRjS0pTVmpXR183ZFpHTnVTc0s2aUR5bmRrWlVuMEp5V3RDZmpySDFWQnV3aVBEN3dZeW4zdUVkQW5nQnl2Zlpp?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"finance.yahoo.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOZTJmNDVxeVNLMERaZWkxbUZxSTBOLVpOdUM5MHV5MEVoYVZUczd6Ty11T3pKSXBmWFpKVGp6Ukw1NzBpYkltUlF3SG5XSnREVHRjdGNxU0NGbTJITGtYT2U1UTVkOS1zWEZmOGRjS0pTVmpXR183ZFpHTnVTc0s2aUR5bmRrWlVuMEp5V3RDZmpySDFWQnV3aVBEN3dZeW4zdUVkQW5nQnl2Zlpp?oc=5","source_event_id":"evt_0664823c7009","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"99520644ccf1f2ce","published_at":"2026-04-18T12:24:26+00:00","publisher_domain":"finance.yahoo.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance","Source summary: Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know Yahoo Finance"],"numeric_claims":[],"primary_claim":"Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know Yahoo Finance","topics":["news headline"]},"source":"Yahoo Finance","source_domain":"finance.yahoo.com","source_url":"https://finance.yahoo.com","summary":"Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know Yahoo Finance","title":"Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}... |